📢 Stocks Trending NOW: #BAC #ASML #GLND #BLK #LQDA #GRML #MS #CRWV #AEHL #VSTM

#VSTM Verastem Oncology Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

https://www.stocktitan.net/news/VSTM/verastem-oncology-announces-pricing-of-250-million-offering-of-ryb8rygdp2zl.html?utm_source=stocktitan-bluesky&utm_medium=social

#VSTM Verastem Oncology Announces Planned Chief Executive Officer Transition and Succession Plan

https://www.stocktitan.net/news/VSTM/verastem-oncology-announces-planned-chief-executive-officer-r7ha6kqaofqb.html?utm_source=stocktitan-bluesky&utm_medium=social

#VSTM VS-7375 Demonstrates Robust Anti-Tumor Activity Across Advanced KRAS G12D-Mutant Cancers, Highlighted by 50% Confirmed O…

https://www.stocktitan.net/news/VSTM/vs-7375-demonstrates-robust-anti-tumor-activity-across-advanced-kras-ddyz2obb9ht1.html?utm_source=stocktitan-bluesky&utm_medium=social

#VSTM Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

https://www.stocktitan.net/news/VSTM/verastem-oncology-announces-inducement-grants-under-nasdaq-listing-erokbqur1iyk.html?utm_source=stocktitan-bluesky&utm_medium=social

BREAKING NEWS: ( NASDAQ: $VSTM ) Verastem Oncology to Unveil New Clinical Data Highlighting the Best-in-Class Potential of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, Across Pancreatic, Lung, and Colorectal Cancers